查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
至 2030 年 ELISA 測試市場預測：按類型、技術、應用、最終用戶和地區分類的全球分析
市場調查報告書
商品編碼
1383390

至 2030 年 ELISA 測試市場預測：按類型、技術、應用、最終用戶和地區分類的全球分析

Elisa Tests Market Forecasts to 2030 - Global Analysis By Type (Indirect ELISA, Sandwich ELISA, Competitive ELISA and Multiple and Portable ELISA), Technology (Chemiluminescent, Colorimetric and Fluorescent), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球 ELISA 檢測市場規模為 25.5 億美元，預計在預測期內將以 8.9% 的年複合成長率成長，並在 2030 年達到 46.4 億美元。

酵素結合免疫吸附測定法是一種標準測定技術，用於識別和定量血液中的抗體、荷爾蒙、胜肽和蛋白質。 ELISA 測試常用於藥物品管測試，例如內毒素測定和蛋白質定量，對於許多病毒性疾病的診斷至關重要。 ELISA是植物病理學和醫學中的診斷技術，也是許多不同領域的品管測試。酵素結合免疫吸附檢測法(ELISA) 測試經常在醫學和植物病理學等各個領域用作品質保證測試和篩選儀器。

根據世界衛生組織 (WHO) 統計，2020 年約有 3,770 萬人感染愛滋病毒。

對早期準確診斷的需求不斷成長

有效的疾病管理和治療依賴早期和準確的診斷。 ELISA 測試的高靈敏度和特異性使醫療保健專業人員能夠識別和檢測患者樣本中的特定生物標記。早期診斷可以立即開始治療並顯著改善患者的治療效果。此外，對這些生物標記的快速識別使醫護人員能夠進行干涉並快速實施有效的治療技術。由於對早期準確診斷的需求，ELISA 檢測市場正在擴大。

嚴格的政府法規

診斷藥物的行銷很困難，因為有些產品被歸類為醫療設備，儘管它們的目的是供醫生用於診斷。如果沒有成功的臨床試驗，這類設備就無法推出，這是一個耗時、昂貴且不確定的過程。不同國家對這些設備的認證有不同的規則，這對國際公司來說是一個重大挑戰。此外，如果各種法規機構（例如 FDA）在產品開發過程中改變法規，則可能會出現潛在的產品推出延遲。這些嚴格的政府法規是市場成長的主要障礙。

技術開發

ELISA 測試市場受益於技術發展，例如自動化系統的創建、多重功能以及檢測靈敏度和特異性的改進。技術進步創造了自動化 ELISA 系統，消除了體力勞動並提高了效率。自動化平台可以同時處理多個樣品，從而簡化測試程序並提高吞吐量。此外，透過減少週轉時間並提高實驗室效率，該技術使醫護人員能夠有效地進行大量測試。由於這些新興市場的開拓提高了功效、準確性和生產力，從而推動了市場需求，ELISA 測試在許多醫療保健環境中已廣泛應用。

競爭替代技術

即時檢測 (POCT) 設備、次世代定序(NGS) 和分子診斷技術（例如 PCR）等替代診斷技術與市場上的 ELISA 檢測競爭。這些創新具有快速週轉時間、更高的靈敏度以及同時檢測多種分析物的能力等優點。隨著這些技術的發展和變得更加廣泛應用，它們可能會取代 ELISA 測試或與 ELISA 測試競爭，特別是在分子診斷具有明顯優勢的領域。 ELISA 檢測市場可能會受到這些替代技術的可用性和普及的威脅。

COVID-19 的影響

最初，在 COVID-19 爆發期間，沒有特定的診斷測試來識別患者的疾病。最初嘗試了替代診斷方法，但成效有限。此外，某些 COVID-19 診斷測試的無法提供為診斷試劑盒製造商提供了銷售 COVID-19 診斷產品的有利可圖的機會。利用這個機會，許多老字型大小企業以及來自各國的新興企業不僅向當地市場而且還向全球市場提供了COVID-19診斷試劑盒。

三明治 ELISA 部分預計將在預測期內成為最大的部分

夾心 ELISA 部分估計佔據最大佔有率。使用由兩層抗體（捕獲抗體和檢測抗體）組成的夾心 ELISA檢測抗原。標靶抗原上的兩個抗原位點已準備好與抗體結合。在夾心ELISA方法中，使用單株或多株抗體來捕捉和辨識抗體。夾心 ELISA 最適合檢測免疫反應，這一事實正在推動市場的擴張。夾心ELISA利用多種抗體來辨識和檢測相同抗原，也是最靈敏的檢測方法。它也非常彈性和具體。

預計感染疾病領域在預測期內年複合成長率最高

預計感染疾病領域在預測期內將出現良好成長。由於慢性病和傳染病的盛行率不斷增加，感染疾病目前主導著ELISA市場的應用領域。酵素結合免疫吸附和觀察ELISA 測試占主導地位，因為它們是自動化的、易於執行，並且不需要放射性材料或昂貴的輻射設備。

比最大的地區

由於其高度發達的醫療保健系統和不斷成長的醫療設備可用性，北美在預測期內佔據了最大的市場佔有率。製藥公司和政府機構針對糖尿病和慢性病等疾病的研發支出的增加也有助於預測期內該地區 ELISA 檢測市場的成長。

複合年複合成長率最高的地區：

由於新興經濟體可支配所得和醫療保健支出的增加，預計歐洲在預測期內將出現盈利成長。由於已開發國家醫療設備的使用不斷增加，ELISA 檢測市場預計在未來年度將成長。此外，由於老年人口眾多以及研發投入龐大，預計在預測期內歐洲大陸非傳染性疾病的發生率也會增加，從而增加對 ELISA 檢測的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球ELISA 檢測市場：按類型

  • 間接ELISA
  • 夾心ELISA
  • 競爭ELISA
  • 多種攜帶式 ELISA

第6章 全球ELISA 檢測市場：依技術分類

  • 化學冷光
  • 比色分析
  • 螢光

第7章 全球ELISA 檢測市場：依應用分類

  • 感染疾病
  • 蛋白質定量
  • 疫苗開發
  • 癌症
  • 免疫學
  • 其他用途

第8章 全球ELISA 測試市場：依最終用戶分類

  • 製藥和生物技術公司
  • 學術研究中心
  • 臨床實驗室
  • 醫院和診斷中心
  • 其他最終用戶

第9章 全球ELISA 檢測市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Abbott Laboratories
  • Danaher Corporation
  • BioMerieux SA
  • Quidel Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific, Inc.
  • ZEUS Scientific, Inc.
  • Hoffmann-La Roche AG
  • PerkinElmer, Inc.
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • R&D Systems, Inc.
  • Bruker
  • Eurofins Scientific
  • ELISA Technologies, Inc
  • BioLegend, Inc
Product Code: SMRC24240

According to Stratistics MRC, the Global Elisa Tests Market is accounted for $2.55 billion in 2023 and is expected to reach $4.64 billion by 2030 growing at a CAGR of 8.9% during the forecast period. The enzyme-linked immune sorbent assay is the standard assay technique used to identify and quantify antibodies, hormones, peptides, and proteins in the blood. The ELISA test is often used in pharmaceutical quality control tests like endotoxin assays and protein quantification and is crucial in the diagnosis of a number of viral diseases. ELISA is a diagnostic technique in plant pathology and medicine as well as a quality control checks in many different sectors. Enzyme-linked immune sorbent assay (ELISA) testing is frequently used as a quality assurance check and screening instrument in a variety of fields, including medicine and plant pathology.

According to the World Health Organization (WHO), around 37.7 million people had HIV in 2020.

Market Dynamics:

Driver:

Rising demand for early and accurate diagnosis

Effective illness management and therapy rely on early and precise diagnosis. The high sensitivity and specificity of Elisa testing enable medical personnel to identify and measure particular biomarkers in patient samples. Early diagnosis enables quick treatment beginning, which can greatly enhance patient results. Additionally, healthcare practitioners can intervene and swiftly implement effective treatment techniques by quickly recognizing these biomarkers. The market for Elisa testing is expanding due to the demand for early and accurate diagnosis.

Restraint:

Stringent government regulations

The marketing of diagnostic products is difficult because some products are categorized as medical devices even though they are intended for use in diagnostic procedures by doctors. Without successfully completing clinical trials, which are a time-consuming, expensive, and uncertain process, such devices cannot be launched. The reality that different countries have different rules for these devices' certification is a significant challenge for international corporations. Additionally, any modifications to rules made by various regulatory agencies, like the FDA, during the product development process may cause a delay in the introduction of potential products. These stringent government regulations are the major barriers to market growth.

Opportunity:

Technological developments

The market for Elisa testing has benefited from technological developments such as the creation of automated systems, the ability to multiplex and enhanced sensitivity and specificity of assays. Technological improvements have led to the creation of automated Elisa systems, excluding manual labor and enhancing efficiency. Multiple samples can be handled simultaneously by automated platforms, streamlining the testing procedure and boosting throughput. Furthermore, by speeding up turnaround times and increasing laboratory efficiency, this technology enables healthcare practitioners to efficiently perform a higher volume of tests. Elisa tests are becoming more widely used in many healthcare settings as a result of these developments, which improve their effectiveness, accuracy, and productivity, which drives market demand.

Threat:

Alternative technologies' competition

Alternative diagnostic technologies, such as point-of-care testing (POCT) devices, next-generation sequencing (NGS), and molecular diagnostic techniques (e.g., PCR), compete with Elisa tests on the market. These innovations have benefits like quicker turnaround times, greater sensitivity, and the capacity to detect multiple analytes at once. Elisa tests may be replaced or competed with as these technologies develop and become more widely available, especially in areas where molecular diagnostics have clear advantages. The market for Elisa tests may be threatened by the availability and uptake of these substitute technologies.

COVID-19 Impact

Initially, in the COVID-19 epidemic, there were no particular diagnostic tests available to identify the illness in patients. Initially, alternative diagnostic procedures were attempted, but they were not very successful. Additionally, due to the unavailability of certain COVID-19 diagnostic tests, diagnostic kit manufacturers had profitable chances to market their COVID-19 diagnostic products. Utilizing this chance, many established companies as well as a few start-ups from different nations offered COVID-19 diagnostic kits to local as well as global markets.

The sandwich ELISA segment is expected to be the largest during the forecast period

The sandwich ELISA segment is estimated to hold the largest share. Antigen is measured using a sandwich ELISA, which consists of two layers of antibodies (the capture antibody and the detection antibody). Two antigenic sites on the target antigens are ready to bind to the antibodies. In sandwich ELISA techniques, monoclonal or polyclonal antibodies are employed to capture and recognize antibodies. Sandwich ELISA works the best for detecting immunological responses, and this fact is promoting market expansion. Sandwich ELISA, which uses a variety of antibodies to bind to the same antigen for recognition or detection, is also the most sensitive test available. It also has a high degree of flexibility and higher specificity.

The infectious diseases segment is expected to have the highest CAGR during the forecast period

The infectious diseases segment is anticipated to have lucrative growth during the forecast period, due to an increase in the prevalence of chronic illnesses and infectious disorders, infectious diseases are now leading the ELISA market's application sector. HIV, HBV, HCV, HTLV, Diphtheria, Giardiasis, and several other infectious blood-borne illnesses The application sector of the enzyme-linked immune sorbent assay (ELISA) testing market is dominated by ELISA tests because they provide quick and accurate findings, have high sensitivity, are automated and simple to perform, and do not require radioactive materials or expensive radiation gear.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the highly developed healthcare system and the growing use of medical gadgets. Rising R&D expenditures by pharmaceutical firms and government organizations for disorders and diseases, including diabetes and chronic illnesses, would also contribute to the market growth for ELISA tests in this region during the projected period.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period due to the rising disposable income and healthcare expenditure in emerging nations. The market for ELISA tests is anticipated to grow in the coming years as a result of the rising use of medical equipment in developed nations. Additionally, due to the large geriatric population and significant investment in research and development, in the projected time frame, it is also anticipated that the rising frequency of non-communicable diseases on the European continent will increase demand for ELISA testing.

Key players in the market

Some of the key players in the Elisa Tests Market include: Abbott Laboratories, Danaher Corporation, BioMerieux SA, Quidel Corporation, Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., ZEUS Scientific, Inc., Hoffmann-La Roche AG, PerkinElmer, Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., R&D Systems, Inc., Bruker, Eurofins Scientific, ELISA Technologies, Inc and BioLegend, Inc.

Key Developments:

In May 2023, Abbott, a global leader in health care and nutrition, has partnered with Real Madrid, one of the most successful and popular football clubs in the world, to inaugurate the Abbott-Real Madrid Innovation Lab, a space for collaboration and research on the future of sports physiology and nutrition.

In March 2023, Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.

In November 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test.

Types Covered:

  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Multiple and Portable ELISA

Technologies Covered:

  • Chemiluminescent
  • Colorimetric
  • Fluorescent

Applications Covered:

  • Infectious Diseases
  • Protein Quantitation
  • Vaccine Development
  • Cancer
  • Immunology
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Hospitals and Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 TechnologyAnalysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Elisa Tests Market, By Type

  • 5.1 Introduction
  • 5.2 Indirect ELISA
  • 5.3 Sandwich ELISA
  • 5.4 Competitive ELISA
  • 5.5 Multiple and Portable ELISA

6 Global Elisa Tests Market, By Technology

  • 6.1 Introduction
  • 6.2 Chemiluminescent
  • 6.3 Colorimetric
  • 6.4 Fluorescent

7 Global Elisa Tests Market, By Application

  • 7.1 Introduction
  • 7.2 Infectious Diseases
  • 7.3 Protein Quantitation
  • 7.4 Vaccine Development
  • 7.5 Cancer
  • 7.6 Immunology
  • 7.7 Other Applications

8 Global Elisa Tests Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical and Biotech Companies
  • 8.3 Academic Research Centers
  • 8.4 Clinical Laboratories
  • 8.5 Hospitals and Diagnostic Centers
  • 8.6 Other End Users

9 Global Elisa Tests Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Danaher Corporation
  • 11.3 BioMerieux SA
  • 11.4 Quidel Corporation
  • 11.5 Siemens Healthineers
  • 11.6 Sysmex Corporation
  • 11.7 Bio-Rad Laboratories
  • 11.8 Ortho Clinical Diagnostics
  • 11.9 Thermo Fisher Scientific, Inc.
  • 11.10 ZEUS Scientific, Inc.
  • 11.11 Hoffmann-La Roche AG
  • 11.12 PerkinElmer, Inc.
  • 11.13 Enzo Life Sciences, Inc.
  • 11.14 Agilent Technologies, Inc.
  • 11.15 R&D Systems, Inc.
  • 11.16 Bruker
  • 11.17 Eurofins Scientific
  • 11.18 ELISA Technologies, Inc
  • 11.19 BioLegend, Inc

List of Tables

  • Table 1 Global Elisa Tests Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 4 Global Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 5 Global Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 6 Global Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 7 Global Elisa Tests Market Outlook, By Technology(2021-2030) ($MN)
  • Table 8 Global Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 9 Global Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 10 Global Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 11 Global Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 13 Global Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 14 Global Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 15 Global Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 16 Global Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 17 Global Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 20 Global Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 21 Global Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 22 Global Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 23 Global Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 24 North America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 26 North America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 27 North America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 28 North America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 29 North America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 30 North America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 31 North America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 32 North America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 33 North America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 34 North America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 North America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 36 North America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 37 North America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 38 North America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 39 North America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 40 North America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 43 North America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 44 North America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 45 North America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 46 North America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 47 Europe Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 49 Europe Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 50 Europe Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 51 Europe Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 52 Europe Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 53 Europe Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 54 Europe Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 55 Europe Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 56 Europe Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 57 Europe Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 59 Europe Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 60 Europe Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 61 Europe Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 62 Europe Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 63 Europe Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 64 Europe Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Europe Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 66 Europe Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 67 Europe Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 68 Europe Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 69 Europe Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 70 Asia Pacific Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 72 Asia Pacific Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 73 Asia Pacific Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 74 Asia Pacific Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 75 Asia Pacific Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 76 Asia Pacific Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 77 Asia Pacific Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 78 Asia Pacific Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 79 Asia Pacific Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 80 Asia Pacific Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 81 Asia Pacific Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 82 Asia Pacific Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 83 Asia Pacific Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 84 Asia Pacific Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 85 Asia Pacific Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 86 Asia Pacific Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 87 Asia Pacific Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Asia Pacific Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 89 Asia Pacific Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 90 Asia Pacific Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 91 Asia Pacific Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 92 Asia Pacific Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 93 South America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 95 South America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 96 South America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 97 South America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 98 South America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 99 South America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 100 South America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 101 South America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 102 South America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 103 South America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 104 South America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 105 South America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 106 South America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 107 South America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 108 South America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 109 South America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 110 South America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 South America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 112 South America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 113 South America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 114 South America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 115 South America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 116 Middle East & Africa Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 118 Middle East & Africa Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 119 Middle East & Africa Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 120 Middle East & Africa Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 121 Middle East & Africa Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 122 Middle East & Africa Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 123 Middle East & Africa Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 124 Middle East & Africa Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 125 Middle East & Africa Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 126 Middle East & Africa Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 127 Middle East & Africa Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 128 Middle East & Africa Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 129 Middle East & Africa Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 130 Middle East & Africa Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 131 Middle East & Africa Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 133 Middle East & Africa Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 134 Middle East & Africa Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 135 Middle East & Africa Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 136 Middle East & Africa Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 137 Middle East & Africa Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 138 Middle East & Africa Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)